PHARMACEUTICAL INDUSTRY PULSE 2025-11-18

PHARMACEUTICAL INDUSTRY PULSE 2025-11-18

Contents
ShowHide

    I.Market Economics

    1.J&J Advocates Healthcare Investment in Spain:Every euro invested in medicine can reduce healthcare costs sevenfold, emphasizing ROI for pharmaceutical investments.(ID:20033200)

    2.Andalusia Leads Spanish Pharmaceutical Spending:Regional spending growth of 1.6% in 2025 highlights sustained market opportunities in Spain.(ID:19913744)

     

    II.Regulatory Affairs

    1.Dutch Prosecutors Link 49 Deaths to Illegal Online Drug Sales:The case underscores the risks of unregulated online pharmacies and the need for robust compliance measures.(ID:19980106)

    2.Vietnamese Pharma Company Fined for Unapproved Medication Sales:Authorities imposed a 195 million VND fine and operational suspension, stressing the importance of regulatory adherence.(ID:19888355)

    3.Korea Launches Pharma Expense Disclosure Platform:The system increases transparency by automatically checking and publicly reporting company expenses to healthcare professionals.(ID:19918870)

     

    III.Supply Chain Challenges

    1.Turkish Pharmacy Crisis Deepens with Drug Shortages:Currency mismatch between official and real exchange rates causes a 20% increase in drug unavailability, affecting patient care.(ID:19971048)

    2.Greece Faces Plasma-Derived Drug Shortages:40% of patients rely on plasma treatments, highlighting supply chain vulnerabilities in specialty medicines.(ID:19953651)

    3.Romanian Pensioners Struggle with Medication Access:Budget constraints leave over 2 million retirees unable to afford basic treatments, indicating market access challenges.(ID:20045756)

     

    IV.Corporate Highlights

    1.Sanofi Thailand Recognized for CSR Efforts:Winning the AmCham CSI Award for the sixth year reinforces the value of sustainable healthcare practices.(ID:19988415)

     

    V.Workforce Trends

    1.Pharmaceutical Salaries Rise 12% in the United States:Growing demand for specialized research roles drives salary increases, impacting talent acquisition costs.(ID:19882586)

     

     

    Disclaimer: This is a curated digest of industry news from public sources. The information is for general insight and is not professional advice; readers should verify details independently. Please provide news ID when you need the original url.

    PHARMACEUTICAL INDUSTRY PULSE

    PHARMACEUTICAL INDUSTRY PULSE

    PERSONAL CARE PULSE 2025-11-18

    I.Market Trends 1.GST Transition Impacts FMCG Demand:The new GST regime in India caused a 5.4% drop in FMCG volumes, highlighting regulatory effects on market dynamics.(ID:20020051) 2.Soap

    Read More »
    Contact Us
    ORID

    Contact Us